Substance P in human hand veins in vivo: Tolerance, efficacy, potency, and mechanism of venodilator action

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 4, 1996, Pages 435-443

  Strobel, Werner M ^a   Lüscher, Thomas F ^a   Simper, David ^a   Linder, Lilly ^a   Haefeli, Walter E ^a,b  

^a University Hospital of Psychiatry   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BRADYKININ; ENALAPRIL MALEATE; ENALAPRILAT; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBURIDE; LYSINE ACETYLSALICYLATE; N(G) METHYLARGININE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL; SUBSTANCE P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; FEMALE; HAND; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASODILATATION; VOLUNTEER;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; GLYBURIDE; HAND; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; SUBSTANCE P; VASOCONSTRICTOR AGENTS; VASODILATION; VEINS;

EID: 0029908889     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90200-3     Document Type: Article

References (42)

1. Hökfelt T, Kellerth JO, Nillson G, Pernow B. Experimental immunohistochemical studies on the localisation and distribution of substance P in cat primary sensory neurons. Brain Res 1975;100:235-52.
2. Lundberg J, Hökfelt T, Kewenter J. Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterol 1979;77:468-71.
3. Hökfelt T, Elfvin LG, Schultzberg M, Goldstein M, Nilsson G. On the occurrence of substance P-containing fibres in sympathetic ganglia: immunhistochemical evidence. Brain Res 1977;132:29-41.
4. Pernow B. Substance P. Pharmacol Rev 1983;35:85-141.
5. Weihe E, Reinecke M, Opherk D, Forssmann W. Peptidergic innervation (substance P) in the heart. J Mol Cell Cardiol 1981;13:331-3.
6. Eklund B, Jogestrand T, Pernow B. Effect of substance P on resistance and capacitance vessels in the human forearm. In: Euler US, Pernow B, editors. Substance P (Nobel Symposium 37). New York: Raven Press, 1977:275-85.
7. Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-90.
8. McEwan JR, Benjamin N, Larkin S, Fuller RW, Dollery CT, MacIntyre I. Vasodilation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation 1988;77:1072-80.
9. Bolton TP, Clapp LH. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol 1986;87:713-23.
10. Malomvölgyi B, Hadhazy P, Magyar K. Endothelium-dependent vasodilator actions of acetylcholin, calcium-ionophore (A23187) and substance P in perfused renal arteries from rabbits. Arch Int Pharmacodyn 1988;291:113-21.
11. Zawadzki JV, Furchgott RF, Cherry P. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by substance P [abstract]. Fed Proc 1981;40:689.
12. Takahashi K, Tanaka A, Kara M, Nakanishi S. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur J Biochem 1992;204:1025-33.
13. Takeda Y, Chou KB, Takeda BS, Sachais BS, Krause JE. Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 1991;179:1232-40.
14. Luu TN, Chester AH, O'Neil GS, Tadjkarimi S, Yacoub MH. Effects of vasoactive neuropeptides on human saphenous vein. Br Heart J 1992;67:474-7.
15. Chester AH, O'Neil GS, Tadjkarimi S, Palmer RMJ, Moncada S, Yacoub MH. The role of nitric oxide in mediating endothelium-dependent relaxations in the human epicardial coronary artery. Int J Cardiol 1990;29: 305-9.
16. Bény JL, PC Brunet. Electrophysiological and mechanical effects of substance P and acetylcholine on rabbit aorta. J Physiol London 1988;398:277-89.
17. Bény JL, PC Brunet. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilation of pig coronary arteries. Blood Vessels 1988;25:308-11.
18. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels 1990;27:238-45.
19. Benjamin N, Webb DJ. The effect of local converting enzyme inhibition on the dilator response to substance P in the human forearm. Br J Clin Pharmacol 1990;29:774-6.
20. Yokosawa H, Endo S, Ohgaki Y, Maeyama J, Ishii S. Hydrolysis of substance P and its analogs by angiotensin-converting enzyme from rat lung. Characterization of endopeptidase activity of the enzyme. J Biochem 1985;98:1293-9.
21. Casceiri MA, Bull HE, Mumford RA, Patchett AA, Thornberry NA, Liang T. Carboxy-terminal tripeptide hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol 1983;25:287-93.
22. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993;52:1461-80.
23. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 1981; 11:237-43.
24. Haefeli WE, Gumbleton M, Benet LZ, Hoffman BB, Blaschke TF. Comparison of vasodilatory responses to nitroglycerin and its dinitrate metabolites in human veins. Clin Pharmacol Ther 1992;52:590-6.
25. Flower RS. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974;26:33-67.
26. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-102.
27. Fleming WW, Westfal DP, De La Lande IS, Jellett LB. Log-normal distribution of effective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 1972;181:339-45.
28. Dachman WD, Ford GA, Blaschke TF, Hoffman BB. Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol 1993;21:241-8.
29. Eichler HG, Blöchl-Daum B, Kyrie PA, Gasic S. Cilazapril and enalapril inhibit local angiotensin I conversion in human hand veins but lack direct venodilating properties. J Cardiovasc Pharmacol 1989;14:248-52.
30. Ford GA, Hoffman BB, Vestal RE, Blaschke TF. Age-related changes in adenosine and β-receptor responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol 1992;33:83-7.
31. Krause JE, Takeda Y, Hershey AD. Structure, function and mechanism of substance P receptor action. J Invest Dermatol 1992;98:2S-7S.
32. Sibley DR, Lefkowitz RJ. Molecular mechanism of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase as a model. Nature 1985;317:124-9.
33. + channels in arterial smooth muscle. Science 1989;245:177-80.
34. Katzir D, Pershe RA, Hoffman BB, Blaschke TF. Comparison of effects of different vasodilating agents on human dorsal hand veins in vivo [abstract]. Clin Res 1986;34:401A.
35. 2α on superficial hand veins of man. Br J Pharmacol 1972;44:374P-5P.
36. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 1995;16:23-9.
37. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.
38. Zhang G, Yamamoto Y, Miwa K, Suzuki H. Vasodilation induced by substance P in guinea pig carotid arteries. Am J Physiol 1994;266:H1132-7.
39. Nagao T, Vanhoutte PM. Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am J Physiol 1991; 261:H1034-7.
40. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterinemic humans. J Clin Invest 1990;86:228-34.
41. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
42. Kushwaha S, Crossman DC, Bustami M, Davies GJ, Mitchell AG, Maseri A, et al. Substance P for evaluation of coronary endothelial function after cardiac transplantation. J Am Coll Cardiol 1991;17:1537-44.